MOODY LYNN LIEBERSON & WALKER, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 938592
BOSTON, MA
Position in REGN
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$2,402,137
-$183,627 QoQ
Shares Held
3,109
-7.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MOODY LYNN LIEBERSON & WALKER, LLC holds $28,212,439 across 3 Biotechnology names.
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,402,137 | 3,109 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,585,764 | 3,350 | Shares | Sole | 2026-01-15 | |
| 2024-09-30 | $280,681 | 267 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,074,152 | 1,022 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $4,403,391 | 4,575 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $3,969,870 | 4,520 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $219,730 | 267 | Shares | Sole | 2023-10-24 | |
| 2023-03-31 | $3,504,422 | 4,265 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,080,040 | 4,269 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,944,230 | 4,274 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $4,528,646 | 7,661 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $5,618,788 | 8,045 | Shares | Sole | 2022-04-27 | |
| 2021-09-30 | $3,913,699 | 6,467 | Shares | Sole | 2021-10-26 | |
| 2020-06-30 | $5,680,204 | 9,108 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $2,630,418 | 5,387 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||